Compare Ares Capital Corporation (ARCC) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ares Capital Corporation vs Tilray Brands Inc — how do they compare? Ares Capital Corporation trades at $19.97 (market cap $14.34B), while Tilray Brands Inc trades at $4.77 (market cap $649.42M). The key difference: Ares Capital Corporation is far larger — about 22.1× Tilray Brands Inc's market cap, and Ares Capital Corporation pays a 9.61% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| ARCC | TLRY | |
|---|---|---|
Market Cap | $14.34B | $649.42M |
Sector | Financials | Health |
52-Week High | $22.68 | $21.00 |
52-Week Low | $17.45 | $3.88 |
Dividend Yield | 9.61% | — |
Enterprise Value | — | $816.55M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ares Capital Corporation
Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing primarily in U.S. middle-market companies with investment opportunities as well as in larger companies. Its portfolio comprises of first lien senior secured loans, second lien senior secured loans, and mezzanine debt (subordinated unsecured loan), which may include equity components that are diversified by industry and sector. The company may invest in preferred and common equity investments to a lesser proportion. Its revenue mainly consists of interest and dividend income received from the investment made.
Read more on ARCC →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
